La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Q-linea Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Q-linea ha un patrimonio netto totale di SEK68.1M e un debito totale di SEK41.5M, che porta il suo rapporto debito/patrimonio netto a 60.9%. Le sue attività totali e le sue passività totali sono rispettivamente SEK159.0M e SEK90.9M.

Informazioni chiave

60.9%

Rapporto debito/patrimonio netto

SEK 41.50m

Debito

Indice di copertura degli interessi	n/a
Contanti	SEK 20.86m
Patrimonio netto	SEK 68.11m
Totale passività	SEK 90.87m
Totale attività	SEK 158.97m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Dec 31

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

May 07

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Jan 11

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

Feb 17

Do Institutions Own Q-linea AB (publ) (STO:QLINEA) Shares?

Dec 26

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( SEK97.9M ) di QLINEA superano le sue passività a breve termine ( SEK82.2M ).

Passività a lungo termine: Le attività a breve termine di QLINEA ( SEK97.9M ) superano le sue passività a lungo termine ( SEK8.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 30.3% ) di QLINEA è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di QLINEA è aumentato da 0.2% a 60.9% negli ultimi 5 anni.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: QLINEA ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: QLINEA ha meno di un anno di liquidità disponibile se il flusso di cassa libero continua a ridursi ai tassi storici del 11.3 % ogni anno

Q-linea Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

Recent updates

Consensus revenue estimates fall by 42%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Q-linea AB (publ) to Report Q1, 2025 Results on May 03, 2025

Q-linea AB (publ) Approves the Election of Jonas Jarvius as Members of the Board of Directors

Consensus revenue estimates increase by 49%

First quarter 2024 earnings released: kr0.48 loss per share (vs kr2.10 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates increase by 24%, EPS downgraded

New minor risk - Profitability

No longer forecast to breakeven

Full year 2023 earnings: EPS and revenues miss analyst expectations

Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024

Q-linea AB (publ) Announces CEO Changes

Q-linea AB (publ) to Report First Half, 2024 Results on Jul 11, 2024

Q-linea AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Forecast to breakeven in 2026

Consensus revenue estimates decrease by 27%

Price target decreased by 13% to kr10.00

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Q-Linea AB (Publ) Announces Jonas Jarvius to Step Down as CEO Before Summer 2024

Q-linea AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 262.885275 million.

New major risk - Share price stability

Consensus revenue estimates decrease by 40%, EPS upgraded

Q-linea AB (publ) Completes its 510(k) Application for US Market Approval

Second quarter 2023 earnings released: kr2.23 loss per share (vs kr2.53 loss in 2Q 2022)

Q-linea AB (publ) Announces First Patient Enrolls in Lifetimes

Consensus revenue estimates increase by 40%, EPS downgraded

Insufficient new directors

Full year 2022 earnings: EPS and revenues miss analyst expectations

CFO & Investor Relations Officer recently bought kr143k worth of stock

Full year 2022 earnings released: kr9.20 loss per share (vs kr8.19 loss in FY 2021)

Q-linea AB (publ) Announces CFO Changes, Effective May 1, 2023

Q-linea AB (publ) Prepare to Start Additional Testing for US 510(K) Application

Q-Linea Participates in Comparative Rapid AST Study

VP & Research Director recently bought kr241k worth of stock

Consensus revenue estimates fall by 21%

Q-linea AB (publ) to Report Q1, 2023 Results on May 04, 2023

Third quarter 2022 earnings released: kr2.03 loss per share (vs kr1.68 loss in 3Q 2021)

Consensus revenue estimates fall by 34%

Second quarter 2022 earnings released: kr2.53 loss per share (vs kr2.47 loss in 2Q 2021)

Consensus revenue estimates fall by 82%

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 22% undervalued after recent price drop

Price target decreased to kr165

Q-linea AB (publ) Announces Marcus Storch Not Available for Re-Election as Member of Board of Directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

CEO & President recently bought kr480k worth of stock

Insufficient new directors

Now 22% undervalued after recent price drop

Price target decreased to kr165

Forecast breakeven date pushed back to 2024

Full year 2021 earnings: EPS and revenues miss analyst expectations

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Forecast to breakeven in 2023

Third quarter 2021 earnings released: kr1.68 loss per share (vs kr1.80 loss in 3Q 2020)

Forecast to breakeven in 2023

Second quarter 2021 earnings released: kr2.47 loss per share (vs kr2.37 loss in 2Q 2020)

CEO & President recently sold kr14m worth of stock

Q-linea AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 301.4 million.

Q-linea AB (publ) Initiates US 510(k) Clinical Study for ASTar

Consensus forecasts updated

First quarter 2021 earnings released: kr2.34 loss per share (vs kr2.44 loss in 1Q 2020)

Full year 2020 earnings released: kr8.64 loss per share (vs kr7.74 loss in FY 2019)

Price target increased to kr185

Q-linea AB (publ) Receives First Order on ASTar

Full year 2020 earnings released: kr8.64 loss per share (vs kr7.74 loss in FY 2019)

Revenue beats expectations

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

New 90-day low: kr150